Advisor Resource Council’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,468
Closed -$868K 277
2026
Q1
$868K Buy
2,468
+26
+1% +$9.27K 0.28% 68
2025
Q4
$842K Buy
+2,442
New +$775K 0.3% 76
2025
Q3
Sell
-984
Closed -$275K 48
2025
Q2
$275K Sell
984
-3,288
-77% -$931K 0.11% 141
2025
Q1
$1.02M Buy
+4,272
New +$1.26M 0.08% 245
2024
Q4
Sell
-1,956
Closed -$630K 79
2024
Q3
$630K Buy
+1,956
New +$640K 0.28% 92
2024
Q2
Sell
-774
Closed -$223K 77
2024
Q1
$223K Sell
774
-2,181
-74% -$638K 0.09% 207
2023
Q4
$851K Buy
+2,955
New +$805K 0.1% 199
2022
Q3
Sell
-3,197
Closed -$778K 169
2022
Q2
$778K Buy
+3,197
New +$783K 0.07% 226
2022
Q1
Sell
-2,548
Closed -$573K 231
2021
Q4
$573K Buy
+2,548
New +$538K 0.04% 305
2021
Q3
Sell
-2,623
Closed -$639K 234
2021
Q2
$639K Buy
+2,623
New +$645K 0.07% 268

Other funds holding AMGN

Advisor Resource Council's AMGN Position: Q2 2026 in Review

Advisor Resource Council sold out of Amgen (AMGN) in Q2 2026, closing a stake of 2,468 shares — an estimated $868K sold.

Advisor Resource Council first reported a position in AMGN in Q2 2021 and held it in 10 quarters. The position peaked at $1.02M in Q1 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advisor Resource Council reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Advisor Resource Council sold 2,468 Amgen shares in Q2 2026, an estimated $868K.
  • Advisor Resource Council first reported a position in Amgen in Q2 2021 and held it in 10 quarters.
  • Advisor Resource Council's Amgen position peaked at $1.02M in Q1 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advisor Resource Council's 13F filing for Q2 2026, filed 28 Jul 2026.